Intensive Care Unit Stay and Mechanical Ventilation Among Adults with Respiratory Syncytial Virus-Related Hospitalization by Age and Comorbidity Status [0.03%]
按年龄和合并症状态划分的住院成人呼吸合胞病毒患者的重症监护时间和机械通气时间
Caihua Liang,Yun Zhou,Matthew Kent et al.
Caihua Liang et al.
Introduction: Respiratory syncytial virus (RSV) can cause severe outcomes in hospitalized older adults and those with underlying comorbidities, but little is known regarding such outcomes stratified by age and comorbidity...
A Response to: Letter to the Editor Regarding "The Risk of Herpes Zoster in Patients with Depressive Disorders: A German Claims Database Analysis" [0.03%]
关于“抑郁症患者带状疱疹发病风险——基于德国医疗数据库的分析”的来信回复
Pavo Marijic,Julian Witte,Bastian Surmann et al.
Pavo Marijic et al.
Letter to the Editor Regarding "The Risk of Herpes Zoster in Patients with Depressive Disorders: A German Claims Database Analysis" [0.03%]
关于“抑郁障碍患者带状疱疹发病风险：基于德国健康保险理赔数据库的分析”一文的来信
Kuan-Fu Liao,Shih-Wei Lai
Kuan-Fu Liao
Clinical Impact of Implementing a Specific Clinical Pathway for the Management of Clostridioides difficile Infection [0.03%]
建立管理难辨梭菌感染特定临床路径的临床影响
Miguel Rodríguez-Fernández,Rocio Herrero,Pilar González-De-La-Aleja et al.
Miguel Rodríguez-Fernández et al.
Introduction: Despite Clostridioides difficile infection (CDI) being a leading healthcare-associated infection with high morbimortality, there is little evidence on specific antimicrobial stewardship program (ASP) interve...
Management and Resolution of Hypersensitivity Pneumonitis-Related Events in Japanese Patients Treated with Amikacin Liposome Inhalation Suspension in the CONVERT and INS-312 Clinical Trials [0.03%]
日本接受阿米卡星脂质体吸入混悬剂治疗的患者在CONVERT和INS-312临床试验中发生的变应性肺炎相关事件的管理与解决
Yoshitaka Yamazaki,Taku Nakagawa,Zhanna Jumadilova et al.
Yoshitaka Yamazaki et al.
In the phase 3 CONVERT trial, amikacin liposome inhalation suspension (ALIS) plus guideline-based therapy (GBT) achieved greater culture conversion than GBT alone in the treatment of refractory Mycobacterium avium complex pulmonary disease ...
Conceptual Methodological Framework for Incorporating Antimicrobial Resistance Considerations in Economic Models for Pneumococcal Conjugate Vaccines [0.03%]
pneumococcal conjugate疫苗经济模型中纳入抗菌药物耐药性考量的概念方法框架
Mark H Rozenbaum,Maria J Tort,Ruth Chapman et al.
Mark H Rozenbaum et al.
Introduction: Antimicrobial resistance (AMR) is a substantial global health threat and economic burden. Vaccines reduce antibiotic use and prevent resistant infections, combating AMR. However, their economic and health be...
Specialist Healthcare Intervention and Follow-up Trends in Post-Acute COVID-19 Hospitalization as Compared to Other Respiratory Infections [0.03%]
与其它呼吸道感染相比急性新冠住院后的专科医疗干预及随访趋势分析
Marta Colaneri,Alessia Antonella Galbussera,Mauro Tettamanti et al.
Marta Colaneri et al.
Introduction: Post-acute sequelae of COVID-19, often referred to as "long COVID," have raised concerns about increased healthcare utilization following hospitalization. Whether these patterns differ significantly from tho...
Efficacy of Lactococcus lactis Strain Plasma in Patients with Mild COVID-19: A Multicenter, Double-Blinded, Randomized-Controlled Trial (PLATEAU Study) [0.03%]
乳酸链球菌Plasma菌株治疗轻症COVID-19患者有效性的多中心、双盲随机对照试验（PLATEAU研究）
Kazuko Yamamoto,Tsuyoshi Inoue,Takaya Ikeda et al.
Kazuko Yamamoto et al.
Introduction: Coronavirus disease 2019 (COVID-19), caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), is still an ongoing public health threat. COVID-19 can be accompanied by prolonged symptoms, known...
Therapeutic Targeting of Viral N-Glycosylation Modification: From Molecular Mechanisms to Clinical Application Prospects [0.03%]
病毒N-糖基化修饰的药物靶向研究：从分子机制到临床应用前景
Dan Wang,Zihao He,Zehong Chen
Dan Wang
Viral diseases represent a significant global health challenge. N-glycosylation, a critical post-translational modification, plays diverse and essential roles throughout the viral life cycle. This review outlines the initiation of N-glycosy...
Baloxavir Marboxil in Chinese Pediatric Patients Aged 1 to < 5 Years with Influenza: Safety and Clinical and Virologic Outcomes [0.03%]
巴洛沙韦用于中国1至
Yuchuan Li,Peng Guo,Chenguang Jia et al.
Yuchuan Li et al.
Introduction: Baloxavir marboxil (baloxavir), a cap-dependent endonuclease inhibitor, has been proven safe and efficacious against influenza and approved for the treatment of influenza in children aged ≥ 5 years in China...